Development of a Dynamic Model for Personalized Risk Assessment in Large B-Cell Lymphoma

▪ Background: Outcomes for patients with diffuse large B-cell lymphoma (DLBCL) remain heterogeneous. Several clinical and molecular risk factors have been described, both at time of diagnosis (i.e., International Prognostic Index and cell of origin) and during therapy (i.e., interim PET scans). Howe...

Full description

Saved in:
Bibliographic Details
Published inBlood Vol. 130; no. Suppl_1; p. 826
Main Authors Kurtz, David M., Scherer, Florian, Jin, Michael, Soo, Joanne, Craig, Alexander, Esfahani, Mohammad S, Chabon, Jacob J, Stehr, Henning, Liu, Chih Long, Tibshirani, Robert, Maeda, Lauren S., Gupta, Neel K., Khodadoust, Michael, Advani, Ranjana H., Levy, Ronald, Newman, Aaron, Westin, Jason R., Gaidano, Gianluca, Rossi, Davide, Diehn, Maximilian, Alizadeh, Ash A.
Format Journal Article
LanguageEnglish
Published Elsevier Inc 08.12.2017
Online AccessGet full text

Cover

Loading…